MicroRNA miR-106a-5p targets forkhead box transcription factor FOXC1 to suppress the cell proliferation, migration, and invasion of ectopic endometrial stromal cells via the PI3K/Akt/mTOR signaling pathway

References

• Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol. 2018;131:557–571.
   PubMed Web of Science ®Google Scholar
• Fukunaga M. Uterus-like mass in the uterine cervix: superficial cervical endometriosis with florid smooth muscle metaplasia? Virchows Arch. 2001;438:302–305.
   PubMed Web of Science ®Google Scholar
• Mounsey AL, Wilgus A, Slawson DC. Diagnosis and management of endometriosis. Am Fam Physician. 2006;74:594–600.
   PubMed Web of Science ®Google Scholar
• Halme J, Hammond MG, Hulka JF, et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol. 1984;64:151–154.
   PubMed Web of Science ®Google Scholar
• Mehedintu C, Plotogea MN, Ionescu S, et al. Endometriosis still a challenge. J Med Life. 2014;7:349–357.
   PubMedGoogle Scholar
• Gaia-Oltean AI, Pop LA, Cojocneanu RM, et al. The shifting landscape of genetic alterations separating endometriosis and ovarian endometrioid carcinoma. Am J Cancer Res. 2021;11:1754–1769.
   PubMed Web of Science ®Google Scholar
• Wang C, Jin A, Huang W, et al. Up-regulation of Bcl-2 by CD147 through ERK activation results in abnormal cell survival in human endometriosis. J Clin Endocrinol Metab. 2015;100:E955–63.
   PubMed Web of Science ®Google Scholar
• Bilotas M, Meresman G, Buquet R, et al. Effect of vascular endothelial growth factor and interleukin-1beta on apoptosis in endometrial cell cultures from patients with endometriosis and controls. J Reprod Immunol. 2010;84:193–198.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Ye M, Yang W, et al. Effect of Mst1 on endometriosis apoptosis and migration: role of Drp1-Related mitochondrial fission and parkin-required mitophagy. Cell Physiol Biochem. 2018;45:1172–1190.
   PubMedGoogle Scholar
• Chung HW, Lee JY, Moon HS, et al. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril. 2002;78:787–795.
   PubMed Web of Science ®Google Scholar
• Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15:429.
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451–5465.
   PubMed Web of Science ®Google Scholar
• Pan YJ, Wei LL, Wu XJ, et al. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5. Cell Death Dis. 2017;8:e3155.
   PubMed Web of Science ®Google Scholar
• He QY, Wang GC, Zhang H, et al. miR-106a-5p suppresses the proliferation, migration, and invasion of osteosarcoma cells by targeting HMGA2. DNA Cell Biol. 2016;35:506–520.
   PubMed Web of Science ®Google Scholar
• Zhi F, Zhou G, Shao N, et al. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK. PloS One. 2013;8:e72390.
   PubMed Web of Science ®Google Scholar
• Zhao L, Gu C, Ye M, et al. Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis. Reprod Biol Endocrinol. 2018;16:4.
   PubMed Web of Science ®Google Scholar
• Gilding LN, Somervaille TCP. The diverse consequences of FOXC1 deregulation in cancer. Cancers (Basel). 2019;11:184.
   PubMed Web of Science ®Google Scholar
• Lehmann OJ, Sowden JC, Carlsson P, et al. Fox’s in development and disease. Trends Genet. 2003;19:339–344.
   PubMed Web of Science ®Google Scholar
• Han B, Bhowmick N, Qu Y, et al. FOXC1: an emerging marker and therapeutic target for cancer. Oncogene. 2017;36:3957–3963.
   PubMed Web of Science ®Google Scholar
• Chin JR, Werb Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development. 1997;124:1519–1530.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387–2392.
   PubMed Web of Science ®Google Scholar
• Xu YL, Wang DB, Liu QF, et al. Silencing of cofilin-1 gene attenuates biological behaviours of stromal cells derived from eutopic endometria of women with endometriosis. Hum Reprod. 2010;25:2480–2488.
   PubMed Web of Science ®Google Scholar
• Liang Z, Chen Y, Zhao Y, et al. miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo. Stem Cell Res Ther. 2017;8:251.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yan J, Pan X. miR-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12. Pflugers Arch. 2019;471:1055–1063.
   PubMed Web of Science ®Google Scholar
• Sultana S, Kajihara T, Mizuno Y, et al. Overexpression of microRNA-542-3p attenuates the differentiating capacity of endometriotic stromal cells. Reprod Med Biol. 2017;16:170–178.
   PubMed Web of Science ®Google Scholar
• Yang WW, Hong L, Xu XX, et al. Regulation of miR-33b on endometriosis and expression of related factors. Eur Rev Med Pharmacol Sci. 2017;21:2027–2033.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Yamashita Y, Iwase A, et al. The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis. Fertil Steril. 2012;98:415–22.e1-12.
   Web of Science ®Google Scholar
• Li Q, Zhang C, Chen R, et al. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett. 2016;383:28–40.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261–275.
   PubMed Web of Science ®Google Scholar
• Bjorkman S, Taylor HS. MicroRNAs in endometriosis: biological function and emerging biomarker candidates†. Biol Reprod. 2019;100:1135–1146.
   PubMed Web of Science ®Google Scholar
• Young VJ, Brown JK, Saunders PT, et al. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update. 2013;19:558–569.
   PubMed Web of Science ®Google Scholar
• Jana S, Rudra DS, Paul S, et al. Curcumin delays endometriosis development by inhibiting MMP-2 activity. Indian J Biochem Biophys. 2012;49:342–348.
   PubMed Web of Science ®Google Scholar
• Paul S, Sharma AV, Mahapatra PD, et al. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res. 2008;44:439–449.
   PubMed Web of Science ®Google Scholar
• Li Q, Wei P, Wu J, et al. The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect. Oncogene. 2019;38:483–496.
   PubMed Web of Science ®Google Scholar
• Zuo H, Yang Q. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging. J buon. 2018;23:720–728.
   PubMed Web of Science ®Google Scholar
• Ray PS, Wang J, Qu Y, et al. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res. 2010;70:3870–3876.
   PubMed Web of Science ®Google Scholar
• Wang J, Li L, Liu S, et al. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT. Oncotarget. 2016;7:84375–84387.
   PubMedGoogle Scholar
• Yu Z, Xu H, Wang H, et al. Foxc1 promotes the proliferation of fibroblast-like synoviocytes in rheumatoid arthritis via PI3K/AKT signalling pathway. Tissue Cell. 2018;53:15–22.
   PubMed Web of Science ®Google Scholar
• Huang L, Huang Z, Fan Y, et al. FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway. Am J Transl Res. 2017;9:1297–1306.
   PubMed Web of Science ®Google Scholar
• Madanes D, Bilotas MA, Bastón JI, et al. PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage. Gynecol Endocrinol. 2020;36:436–440.
   PubMed Web of Science ®Google Scholar
• Samartzis EP, Noske A, Dedes KJ, et al. ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci. 2013;14:18824–18849.
   PubMed Web of Science ®Google Scholar
• Liu Y, Qin X, Lu X, et al. Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model. Can J Physiol Pharmacol. 2019;97:963–970.
   PubMed Web of Science ®Google Scholar
• Wang H, Ni C, Xiao W, et al. Role of lncRNA FTX in invasion, metastasis, and epithelial-mesenchymal transition of endometrial stromal cells caused by endometriosis by regulating the PI3K/Akt signaling pathway. Ann Transl Med. 2020;8:1504.
   PubMed Web of Science ®Google Scholar
• Diao R, Wei W, Zhao J, et al. CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs. Am J Reprod Immunol. 2017;78:78.
   Web of Science ®Google Scholar
• Barra F, Ferro Desideri L, Ferrero S. Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis. Br J Pharmacol. 2018;175:3626–3627.
   PubMed Web of Science ®Google Scholar
• Li X, Zhu Y, Zhang H, et al. MicroRNA-106a-5p inhibited C2C12 myogenesis via targeting PIK3R1 and modulating the PI3K/AKT signaling. Genes (Basel). 2018;9:333.
   Web of Science ®Google Scholar
• Ding X, Xu X, He XF, et al. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Bioengineered. 2021;12:803–814.
   PubMed Web of Science ®Google Scholar
• Xu W, Zhang L, Geng Y, et al. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson’s disease by regulating NLRP3 pathway through sponging miR-223-3p. Int Immunopharmacol. 2020;85:106614.
   PubMed Web of Science ®Google Scholar
• Liu K, Xue B, Bai G, et al. Downregulation of Diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest. Bioengineered. 2021;12:1517–1529.
   PubMed Web of Science ®Google Scholar